RxDoctor Payments Data

Timber Wright

Family · Crockett, TXNPI 1497452320

Payments from drug & device makers

$751in general payments, 2019–2025

Across 40 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$148
  • AstraZeneca$135
  • Lilly USA, LLC$94
  • Amgen$81
  • Pfizer$73
  • Novo Nordisk$41
  • plus $180 from 9 others

What the payments were for

  • Food & beverage$751100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$751 in reported general payments places this provider in the 60th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Medicare billing

Part B allowed, 2024
$4,249
Medicare patients
74
Services billed
218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide34$35,138
MounjaroTirzepatide24$26,640
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$21,655
EliquisApixaban21$16,974
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$5,289
Albuterol Sulfate HfaAlbuterol Sulfate67$1,688
Gabapentin97$1,541
Pregabalin32$907
Atorvastatin Calcium84$672
Famotidine53$631
Methylprednisolone63$514
Lisinopril75$458
Rosuvastatin Calcium36$454
Omeprazole30$443
Potassium Chloride28$373

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$41$35,13834 claims
Lilly USA, LLCMounjaro$94$26,64024 claims
GSKTrelegy Ellipta$16$21,65525 claims
PfizerEliquis$73$16,97421 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 15,456 family providers in Texas.

Other family in Crockett

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →